Pharmacogenetics and pharmacogenomics of endocrine agents for breast cancer

被引：10
|
作者：
Ingle, James N. [1 ]
机构：
[1] Mayo Clin, Rochester, MN 55905 USA
来源：
BREAST CANCER RESEARCH | 2008年 / 10卷 / Suppl 4期
关键词：
D O I：
10.1186/bcr2177
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页数：4
相关论文
共 50 条
  • [11] The role of pharmacogenetics and pharmacogenomics in cancer therapy
    Peters, G.
    EJC SUPPLEMENTS, 2009, 7 (04): : 6 - 7
  • [12] Pharmacogenomics and pharmacogenetics
    Iqbal, O
    PHARMACOGENOMICS, 2005, 6 (03) : 205 - 207
  • [13] Pharmacogenetics and pharmacogenomics
    Leeder, JS
    PEDIATRIC CLINICS OF NORTH AMERICA, 2001, 48 (03) : 765 - +
  • [14] Pharmacogenetics and pharmacogenomics
    Bourel, Michel
    Ardaillou, Raymond
    BULLETIN DE L ACADEMIE NATIONALE DE MEDECINE, 2006, 190 (01): : 9 - 22
  • [15] Pharmacogenetics and pharmacogenomics
    Daly, Ann K.
    PHARMACOGENOMICS, 2007, 8 (11) : 1493 - 1496
  • [16] Pharmacogenetics and pharmacogenomics
    Robert, Jacques
    BULLETIN DU CANCER, 2006, 93 : 113 - 123
  • [17] Pharmacogenetics and pharmacogenomics
    Pirmohamed, M
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2001, 52 (04) : 345 - 347
  • [18] Pharmacogenetics and pharmacogenomics: a bridge to individualized cancer therapy
    Weng, Liming
    Zhang, Li
    Peng, Yan
    Huang, R. Stephanie
    PHARMACOGENOMICS, 2013, 14 (03) : 315 - 324
  • [19] Endocrine agents in the treatment of advanced breast cancer
    Bauerfeind, I
    Untch, M
    GYNAKOLOGE, 1999, 32 (08): : 605 - 613
  • [20] New agents for endocrine resistance in breast cancer
    Maurer, Christian
    Martel, Samuel
    Zardavas, Dimitrios
    Ignatiadis, Michail
    BREAST, 2017, 34 : 1 - 11
12345